The invention relates to the therapeutic use of a second generation immunomodulatory oligonucleotide in combination with HIV-1 antigen or immunogen to enhance the ability to reduce the risk HIV infection and to control the progression of HIV infection to prevent AIDS Related Complex (ARC) and AIDS
Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide / M. Clerici, R. Bartholomew, D. Bray, E. Kandimalla, S. Agrawal.
Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide
M. ClericiPrimo
;
2005
Abstract
The invention relates to the therapeutic use of a second generation immunomodulatory oligonucleotide in combination with HIV-1 antigen or immunogen to enhance the ability to reduce the risk HIV infection and to control the progression of HIV infection to prevent AIDS Related Complex (ARC) and AIDS
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
